4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-084117
Chief Development Officer sold 3,011 shares at $12.04 ($36,252)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kaiser Peter · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-25 | Sale : show line 1 in the form 10b5-1 | −3,011 | $12.04 | $36,252 | 204,093 | D |
| Open-market sales · 3,011 sh · avg $12.04 · $36,252 | ||||||
Loading xslF345X05/tm2524438-4_4seq1.xml…